Does drug effectiveness depend on the individual?
Researchers at ETH Zurich, Switzerland, have demonstrated that there is no definitive reason as to why drug effectiveness varies between people, but rather many...
Detecting early stages of Alzheimer’s disease with new blood test
Researchers at the Royal College of Surgeons in Ireland (RCSI) have developed a new blood test that can diagnose the early stages of Alzheimer's...
Synthetic molecule kills five types of deadly drug-resistant superbugs
The Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR), Singapore, and IBM Research have developed a synthetic...
People with major depressive disorder react stronger to negative memories
People with major depressive disorder (MDD) feel a stronger negative emotion when remembering painful experiences than those without the disorder, a study finds.
The study,...
UK government to cut 20% of calories in popular foods
In a bid to tackle childhood and adult obesity, Public Health England (PHE) and the Department of Health and Social Care (DHSC) are taking...
Hypoglycaemia is unaddressed threat to people with Type 2 diabetes
New research from the Endocrine Society and Avalere Health has found that clinicians are not equipped to identify, assess and manage patients at a...
Increasing inhaled steroid doses not effective for severe asthma symptoms
Researchers have found that increasing the dosage of inhaled steroids when asthma symptoms are exacerbated does not effectively prevent severe flare-ups in children.
The study,...
Study identifies groups that are vulnerable to first-episode psychosis
A survey of almost 3,000 people in Brazil who have experienced first-episode psychosis has found that young men, ethnic minorities and people living in...
Toxic substances affecting health found in carpets sold in the EU
The European Public Health Alliance (EPHA) and the Health and Environment Alliance (HEAL) have warned that toxic substances linked to a variety of long...
Leukaemia anti-cancer drug may work against rare ovarian cancer
A study has found that an anti-cancer drug, ponatinib, which is used to fight leukaemia, has shown promise in tackling a rare and aggressive...
Review for MS drug Zinbryta after cases of inflammatory brain disorders
The European Medicines Agency (EMA) has commenced an urgent review of the multiple sclerosis (MS) medicine Zinbryta, following cases of serious inflammatory brain disorders.
There...
WHO says stay alert and help vulnerable as cold weather grips Europe
A wave of severe cold weather has hit Europe this week, and the World Health Organization has warned people to stay alert and help...
A promising new therapeutic approach to spinal cord injuries
Researchers at Karolinska Institutet, Sweden, have been able to improve functional recovery following spinal cord injuries in mice, paving the way for new therapeutic...
New classification suggests five different types of diabetes
Results of a Swedish study (ANDIS) have indicated that there are more than two types of diabetes, meaning the need for new and better...
Mental health experts oppose gaming disorder classification
36 internationally renowned and respected mental health experts, leading social scientists and academics have banded together to oppose the World Health Organization’s (WHO) plans...
UK Public Health Support Team sent to Nigeria for Lassa fever outbreak
The group of experts in the UK Public Health Rapid Support Team (UK-PHRST) is deploying to Nigeria to support the control of a Lassa...
Could a blood test predict if breast cancer drug palbociclib is helping?
A new study has found a blood test for cancer DNA which could help predict if a woman is responding to the new breast...
Cambridge cancer research centre given prestigious designation
The Cancer Research UK Cambridge Centre has been named a comprehensive cancer centre of excellence by the European Academy of Cancer Sciences (EACS).
Cambridge is...
Imperial highlights four unheard of rare diseases for Rare Disease Day
Researchers at Imperial College London, UK, gathered for Rare Disease Day 2018 to bring attention to four uncommon rare diseases and help highlight the...
University of Denmark invests in secondary metabolites research
The University of Denmark (DTU) is to open a new Center of Excellence of Microbial Secondary Metabolites (CeMiSt), which will help identify why micro-organisms...
